(Q39328657)

11 September 2017

title

Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

11 September 2017

main subject

0 references

Clostridium difficile

0 references

0 references

Maria Oliva-Hemker

10

0 references

author name string

Suchitra K Hourigan

1

1 reference

11 September 2017

Sankar R Chirumamilla

2

1 reference

11 September 2017

Tracy Ross

3

1 reference

11 September 2017

Jonathan E Golub

4

1 reference

11 September 2017

Shervin Rabizadeh

5

1 reference

11 September 2017

Shehzad A Saeed

6

1 reference

11 September 2017

Charles O Elson

7

1 reference

11 September 2017

Ciaran P Kelly

8

1 reference

11 September 2017

Karen C Carroll

9

1 reference

11 September 2017

Cynthia Sears

11

1 reference

11 September 2017

language of work or name

1 reference

1 December 2013

1 reference

Inflammatory Bowel Diseases

11 September 2017

published in

1 reference

11 September 2017

volume

19

1 reference

11 September 2017

issue

13

1 reference

11 September 2017

page(s)

2744-2752

1 reference

Clostridium difficile infection: epidemiology, risk factors and management

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Recent trends in the epidemiology and treatment of C. difficile infection in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Risk factors for Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Clostridium difficile infection and proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Incidence of Clostridium difficile infection in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Clostridium difficile infection and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Serological antibodies in inflammatory bowel disease: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Clostridium difficile colonization in early infancy is accompanied by changes in intestinal microbiota composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Polymerase chain reaction test for Clostridium difficile toxin B gene reveals similar prevalence rates in children with and without inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Clostridium difficile infection and treatment in the pediatric inflammatory bowel disease population

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Recurrence rate of clostridium difficile infection in hospitalized pediatric patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Clostridium difficile infection in newly diagnosed pediatric patients with inflammatory bowel disease: prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Medication use among inflammatory bowel disease patients: excessive consumption of antidepressants and analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Detection of toxigenic Clostridium difficile in pediatric stool samples: an evaluation of Quik Check Complete Antigen assay, BD GeneOhm Cdiff PCR, and ProGastro Cd PCR assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Clostridium difficile infection in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Host and Pathogen Factors forClostridium difficileInfection and Colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000435434.53871.36

10.1097/01.MIB.0000435434.53871.36

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference